Table 1 Characteristics of the 25 patients at baseline and at follow up (8 weeks of treatment)
Variables | Visit 1 (Pre-treatment) | Visit 2 (Post treatment) | p |
|---|---|---|---|
Age (years) | 59.2 [55.2; 63.2] | - | |
Male gender (%) | 13.0 (52.0%) | - | |
Current smoker | 4.0 (16.0%) | - | |
Hypertension | 19.0 (76.0%) | - | |
Cardiovascular disease | 5.0 (20.0%) | - | |
Ischemic heart disease | 4.0 (16.0%) | - | |
Ischemic stroke | 1.0 (4%) | - | |
Medication | |||
ACEI | 10.0 (40.0%) | - | |
β-Adrenergic receptor blocker | 8.0 (32.0%) | - | |
Diuretics | 8.0 (32.0%) | - | |
Calcium channel blocker | 7.0 (28.0%) | - | |
Angiotensin receptor blocker | 4.0 (16.0%) | - | |
Aspirin | 7.0 (28.0%) | - | |
SBP (mmHg) | 149.8 [143.5; 156.1] | 142.7 [137.6; 147.8] | 0.04 |
DBP (mmHg) | 91.5 [87.4; 95.5] | 87.5 [82.8; 92.2] | 0.02 |
BMI (kg/m2) | 28.7 [26.6; 34.2]a | 28.7 [26.7; 34.0]a | 0.79 |
Waist (cm) | 108.5 [104.0; 113.0] | 110.4 [105.5; 115.3] | 0.06 |
FPG (mg/dl) | 136.9 [129.0; 144.8] | 137.6 [129.7; 145.5] | 0.82 |
HbA1c (%) | 6.5 [6.3; 6.8] | 6.5 [6.3; 6.7] | 0.53 |
Lipids | |||
Total cholesterol (mg/dl) | 182.0 [166.0; 220.0]a | 168.0 [151.0; 192.5]a | 0.01 |
HDL cholesterol (mg/dl) | 45.0 [40.1; 50.0] | 44.1 [37.7; 50.5] | 0.88 |
LDL-cholesterol (mg/dl) | 104.0 [93.0; 139.3]a | 102.0 [89.1; 125.6]a | 0.14 |
Triglycerides (mg/dl) | 168.6 [140.2; 197.0] | 114.1 [95.4; 132.8] | <0.001 |
eGFR (ml/min/1.73 m2) | 107.7 [93.4; 122.0] | 96.8 [82.6; 111.1] | 0.007 |
TGO (IU/L) | 20.0 [15.5; 25.0]a | 22.0 [18.0; 26.0]a | 0.10 |
TGP (IU/L) | 22.0 [17.0; 27.0]a | 24.0 [20.0; 28.0]a | 0.48 |